The Content Collaborative™: Combining our digital, design, editorial and creative teams under a single umbrella to develop highly resonant stories that transcend channels. In less than a year, this offering doubled in size, winning content- and creative-specific RFPs that would normally have gone to advertising agencies, and expanding work with existing clients. Global Health, Advocacy and Policy Trifecta: Achieving long-term social impact that addresses societal injustices and disparities requires an integrated approach to communications. The Global Health, Advocacy and Policy Trifecta puts global health agendas and grassroots advocacy at the center of policy efforts to drive change. In 2021, we significantly expanded our work in this area supporting several major pharmaceutical companies with their ESG initiatives.
Healthy Tensions: We introduced a novel framework for getting to breakthrough insights called Healthy Tensions. Healthy Tensions provides a strategic, analytics-based model for revealing insights about the emotions of our target audience, which informs the engagement strategy for how brands and companies connect authentically with people. Revolutionize Realistically: In healthcare, legal and regulatory constraints are often seen as insurmountable barriers to innovative, breakthrough creative work. In response, we developed Revolutionize Realistically, a proprietary approach to creative ideation that vaults us past the tried and true (and boring), while keeping well within the parameters of what's possible. As creative thinkers and makers, we Revolutionize by thinking boldly and without boundaries. As experts focused on health and wellness, we Realistically shape our ideas, helping our clients to successfully navigate the regulatory, legal and stakeholder nuances of the sector.
2021 Growth from Existing Clients
2021 Growth from New Clients
Trends and Challenges
Diversity and inclusionTalent acquisition/retentionProcurement-related issues
Healthcare Marketing Trends
More personalization of communicationsNeed to create more/better content/experiencesHeightened focus on payersIncreased concern over drug pricingIndustry consolidationScrutiny around social mediaImpact of empowered patients/consumersIntensified focus on analytics/ROI/measurementDecreased impact of sales forcesPrograms that go “beyond the pill”Emphasis on specialty drugs/high-science categoriesAdopting a data-science cultureMore digital experimentationWorking from homeOngoing fallout from pandemic
Why data-driven linear is the last piece of the marketing puzzle
Reduce waste, optimize media and achieve cross-channel attribution by unifying television.
Fifth CIIE to bring strong Chinese market to global pharmaceutical enterprises
The Medical Equipment and Healthcare Products exhibition area at the CIIE has become an important platform for global pharmaceutical enterprises to explore the Chinese market and share development opportunities in China.
Video: Why privacy changes demand a better approach to targeting: Real world data
Building custom audience segments can help marketers better reach consumers.
An all-in agency approach to challenging the status quo in oncology marketing
Differentiating science, technology, and brand innovation has never been more important across complex and crowded specialty markets.